Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × avelumab × Lymphoid × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Completed 4 Terminated 3 Withdrawn 1 Unknown 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 11 Dermatologic 9 Head & Neck 5 Gynecologic 5 Breast 5 Tumor-Agnostic 4 Thoracic 3 Gastrointestinal 2 NET 1 Lymphoid 1 Endocrine 1 CNS 1

Conditions

Lymphoma, B-Cell 1

Interventions

Cyclophosphamide 118 Rituximab 112 Doxorubicin 62 Vincristine 58 Prednisone 53 venetoclax 50 fludarabine 46 ibrutinib 45 Lenalidomide 42 Specimen Handling 40 Biopsy 39 obinutuzumab 37 Etoposide 36 acalabrutinib 34 fludarabine phosphate 33 CT-P10 31 Magnetic Resonance Spectroscopy 30 Cytarabine 28 Bendamustine Hydrochloride 27 Methotrexate 26 Dexamethasone 25 Nivolumab 22 zanubrutinib 19 prednylidene 17 pembrolizumab 17 deltacortene 17 Melphalan 17 Calcium Dobesilate 17 Brentuximab Vedotin 16 blinatumomab 15

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03244176 2024-07-30

AvR-CHOP

Austin Health

Phase EARLY_PHASE1 Active not recruiting

Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡